Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy
Gisella Figlioli et al.
CANCERS (2021)
Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
Alicja Lukomska et al.
CANCERS (2021)
Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study
Jaco Oosthuizen et al.
FRONTIERS IN ONCOLOGY (2021)
Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia
Dorra Ben Ayed-Guerfali et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge
M. Bono et al.
ESMO OPEN (2021)
BRCA1 and BRCA2 Germline Mutation Analysis in Hereditary Breast/Ovarian Cancer Families from the Aures Region (Eastern Algeria): First Report
Chiraz Mehemmai et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene
Florentia Fostira et al.
JOURNAL OF MEDICAL GENETICS (2020)
Characteristics of breast cancer in Slovenian patients with germline CHEK2 c.444+1G>A mutation.
Nikola Besic et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls
Supriya Behl et al.
SCIENTIFIC REPORTS (2020)
Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)-Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes
Lorena Incorvaia et al.
CANCERS (2020)
Screening ofBRCA1/2genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC)
Fatima Zahra El Ansari et al.
BMC CANCER (2020)
Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: a series from north of Morocco
Joaira Bakkach et al.
BMC CANCER (2020)
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyondBRCA1/2
Daniele Fanale et al.
CANCERS (2020)
Screening of BRCA1 and BRCA2 germline mutations in unselected triple-negative breast cancer patients: A series from north of Morocco
Mohammed Mansouri et al.
PRECISION MEDICAL SCIENCES (2020)
Identification of Novel BRCA1 and RAD50 Mutations Associated With Breast Cancer Predisposition in Tunisian Patients
Najah Mighri et al.
FRONTIERS IN GENETICS (2020)
Prevalence, spectrum, and founder effect of BRCA1 and BRCA2 mutations in epithelial ovarian cancer from the Middle East
Abdul K. Siraj et al.
HUMAN MUTATION (2019)
A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer
Carol Forbes et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Contribution of BRCA1 5382insC mutation in triple negative breast cancer in Tunisia
Wijden Mahfoudh et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study
Muhammad Usman Rashid et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2019)
High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
Al-Joharah Alhuqail et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication
L. M. Pelttari et al.
CLINICAL GENETICS (2018)
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Timothy R. Rebbeck et al.
HUMAN MUTATION (2018)
Substantial evidence for the clinical significance of missense variant BRCA1 c.5309G>T p.(Gly1770Val)
Emma Tudini et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Population Based Testing for Primary Prevention: A Systematic Review
Ranjit Manchanda et al.
CANCERS (2018)
A Recurrent BRCA2 Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico
Hector J. Diaz-Zabala et al.
CANCERS (2018)
Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan
Muhammad U. Rashid et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile
Carolina Alvarez et al.
ONCOTARGET (2017)
Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients
D. Torres et al.
SCIENTIFIC REPORTS (2017)
PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland
Anna Kluska et al.
BMC MEDICAL GENOMICS (2017)
Prevalence of founder mutations in the BRCA1 and BRCA2 genes among unaffected women from the Bahamas
M. Trottier et al.
CLINICAL GENETICS (2016)
Identification of a founder BRCA1 mutation in the Moroccan population
F. Quiles et al.
CLINICAL GENETICS (2016)
Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer
Sarra Henouda et al.
DISEASE MARKERS (2016)
Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis
Rong Bu et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review
Carlos Andres Ossa et al.
ONCOLOGIST (2016)
First application of next-generation sequencing in Moroccan breast/ovarian cancer families and report of a novel frameshift mutation of the BRCA1 gene
Farah Jouali et al.
ONCOLOGY LETTERS (2016)
Screening of exon 11 of BRCA1 gene using the high resolution melting approach for diagnosis in Moroccan breast cancer patients
Meryam El Khachibi et al.
BMC CANCER (2015)
A high frequency of BRCA mutations in young black women with breast cancer residing in Florida
Tuya Pal et al.
CANCER (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Significant Clinical Impact of Recurrent BRCA1 and BRCA2 Mutations in Mexico
Cynthia Villarreal-Garza et al.
CANCER (2015)
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru
J. Abugattas et al.
CLINICAL GENETICS (2015)
Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia
A. Riahi et al.
CLINICAL GENETICS (2015)
Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients
Felipe C. Silva et al.
BMC MEDICAL GENETICS (2014)
The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas
M. R. Akbari et al.
CLINICAL GENETICS (2014)
Features of breast cancer in developing countries, examples from North-Africa
Marilys Corbex et al.
EUROPEAN JOURNAL OF CANCER (2014)
Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer
Asma Fourati et al.
BULLETIN DU CANCER (2014)
Mutation Screening of the BRCA1 Gene in Early Onset and Familial Breast/Ovarian Cancer in Moroccan Population
Abdelilah Laraqui et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)
The Korean Hereditary Breast Cancer Study: Review and Future Perspectives
Eunyoung Kang et al.
JOURNAL OF BREAST CANCER (2013)
Functional and Structural Analysis of C-Terminal BRCA1 Missense Variants
Francisco Quiles et al.
PLOS ONE (2013)
Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry
Jing Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
BRCA1 and BRCA2 mutations among familial breast cancer patients from Costa Rica
G. A. Gutierrez Espeleta et al.
CLINICAL GENETICS (2012)
Portuguese c.156_157insAlu BRCA2 founder mutation: gastrointestinal and tongue neoplasias may be part of the phenotype
Miguel A. M. Moreira et al.
FAMILIAL CANCER (2012)
Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil
Crisle Vignol Dillenburg et al.
GENETICS AND MOLECULAR BIOLOGY (2012)
BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: Novel mutations and unclassified variants
Amal Tazzite et al.
GYNECOLOGIC ONCOLOGY (2012)
High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients
James D. Fackenthal et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases
Nancy Uhrhammer et al.
International Journal of Medical Sciences (2012)
Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population
Wijden Mahfoudh et al.
MOLECULAR BIOLOGY REPORTS (2012)
Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases
Sandrine Caputo et al.
NUCLEIC ACIDS RESEARCH (2012)
Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast Cancer Patients Using Gene Sequencing and High Resolution DNA Melting Analysis
Ava Kwong et al.
PLOS ONE (2012)
BRCA1 And BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin
Angela Rosaria Solano et al.
SPRINGERPLUS (2012)
A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas
Talia Donenberg et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Family history, BRCA mutations and breast cancer in Vietnamese women
O. M. Ginsburg et al.
CLINICAL GENETICS (2011)
On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations
Nancy Hamel et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Genetic testing and first presymptomatic diagnosis in Moroccan families at high risk for breast/ovarian cancer
Fatima Zahra Laarabi et al.
ONCOLOGY LETTERS (2011)
Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
Ingrid P. Ewald et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2011)
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece
Chrissovaladis Koumpis et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2011)
BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region
Zakaria Einbeigi et al.
ACTA ONCOLOGICA (2010)
High Frequency of BRCA1 Founder Mutations in the Bahamas.
T. Donenberg et al.
CANCER RESEARCH (2010)
BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families
Farid Cherbal et al.
DISEASE MARKERS (2010)
Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer
Luca Cavallone et al.
FAMILIAL CANCER (2010)
Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection
Safinaz S. Ibrahim et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control
Ramunas Janavicius
EPMA JOURNAL (2010)
A PALB2 mutation associated with high risk of breast cancer
Melissa C. Southey et al.
BREAST CANCER RESEARCH (2010)
Novel and common BRCA1 mutations in familial breast/ovarian cancer patients from Lithuania
Ramunas Janavicius et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy
Laura Papi et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor Phenotype
Tuomas Heikkinen et al.
CLINICAL CANCER RESEARCH (2009)
Genomic screening identifies novel linkages and provides further evidence for a role of MYH9 in nonsyndromic cleft lip and palate
Brett T. Chiquet et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
Evidence for an ancient BRCA1 mutation in breast cancer patients of yoruban ancestry
Bifeng Zhang et al.
FAMILIAL CANCER (2009)
BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation
Kannan Vaidyanathan et al.
JOURNAL OF BIOSCIENCES (2009)
The Contribution of BRCA1 and BRCA2 to Ovarian Cancer
Susan J. Ramus et al.
MOLECULAR ONCOLOGY (2009)
BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer
Mads Thomassen et al.
ACTA ONCOLOGICA (2008)
Reconstructing the genealogy of a BRCA1 founder mutation by phylogenetic analysis
F. Marroni et al.
ANNALS OF HUMAN GENETICS (2008)
Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian
Eva Machackova et al.
BMC CANCER (2008)
Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families
Mateja Krajc et al.
BMC MEDICAL GENETICS (2008)
Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer
W. Troudi et al.
CANCER BIOMARKERS (2008)
BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark
Marie Soegaard et al.
CLINICAL CANCER RESEARCH (2008)
Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba
Rolando Comacho Rodriguez et al.
FAMILIAL CANCER (2008)
MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases:: Novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases
Stefanie Engert et al.
HUMAN MUTATION (2008)
BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from northeast Italy
Sandro Malacrida et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients:: evaluation of its pathogenicity and inferences on its genealogical history
Theodore Anagnostopoulos et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
BRCA2 gene mutations in Slovenian male breast cancer patients
Nikola Besic et al.
GENETIC TESTING (2008)
Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups
Esther M. John et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia
Wafa Troudi et al.
JOURNAL OF HUMAN GENETICS (2007)
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily):: a mutation analyses
Antonio Russo et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Genetic epidemiology of BRCA mutations - family history detects less than 50% of the mutation carriers
Pal Moller et al.
EUROPEAN JOURNAL OF CANCER (2007)
Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer
Jacques Simard et al.
JOURNAL OF MEDICAL GENETICS (2007)
Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus
M. Loizidou et al.
CLINICAL GENETICS (2007)
High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia
Diana Torres et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Founder mutations in BRCA1 and BRCA2 genes
R. Ferla et al.
ANNALS OF ONCOLOGY (2007)
Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from Western Sweden
Zakaria Einbeigi et al.
FAMILIAL CANCER (2007)
Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients
Muhammad U. Rashid et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2:: Application in a Dutch cancer clinic setting
Annemarie H. van der Hout et al.
HUMAN MUTATION (2006)
High frequency of BRCA1 5382insC mutation in Russian breast cancer patients
Anna P. Sokolenko et al.
EUROPEAN JOURNAL OF CANCER (2006)
BRCA1 and BRCA2 mutations in a South American population
L Jara et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families
Kathleen K. Oros et al.
BMC MEDICAL GENETICS (2006)
High incidence of 4153delA BRCA1 gene mutations in Lithuanian breast- and breast-ovarian cancer families
J Gronwald et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations -: art. no. e20
B Leegte et al.
JOURNAL OF MEDICAL GENETICS (2005)
High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia
L Tikhomirova et al.
FAMILIAL CANCER (2005)
The BRCA1 exon 13 duplication in the Swedish population
B Kremeyer et al.
FAMILIAL CANCER (2005)
High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area
P Pohlreich et al.
BREAST CANCER RESEARCH (2005)
BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families
K Claes et al.
BRITISH JOURNAL OF CANCER (2004)
Haplotype and cancer risk analysis of two common mutations, BRCA1 4184del4 and BRCA2 2157delG, in high risk northwest England breast/ovarian families -: art. no. e21
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2004)
A high proportion of founder BRCA1 mutations in Polish breast cancer families
B Górski et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
BRCA1 mutations in South African breast and/or ovarian cancer families:: Evidence of a novel founder mutation in Afrikaner families
MD Reeves et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Significant proportion of breast and/or ovarian cancer families of french Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations
KK Oros et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Hereditary breast and ovarian cancer in Cyprus:: identification of a founder BRCA2 mutation
A Hadjisavvas et al.
CANCER GENETICS AND CYTOGENETICS (2004)
Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients:: A high proportion of mutations unique to Spain and evidence of founder effects
O Díez et al.
HUMAN MUTATION (2003)
BRCA1 and BRCA2 mutations in Scotland and Northern Ireland
CM Steel et al.
BRITISH JOURNAL OF CANCER (2003)
Haplotype Analysis of the BRCA2 9254delATCAT Recurrent Mutation in Breast/Ovarian Cancer Families from Spain
Berta Campos et al.
HUMAN MUTATION (2003)
BRCA1 and BRCA2 Sequence Variants in Chinese Breast Cancer Families
Xiangcheng Zhi et al.
HUMAN MUTATION (2002)
BRCA1 and BRCA2 in Indian Breast Cancer Patients
Sunita Saxena et al.
HUMAN MUTATION (2002)
BRCA2 founder mutation in Slovenian breast cancer families
M Krajc et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2002)
Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan
A Liede et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines
MLD Matsuda et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Clustering of individuals with both breast and ovarian cancer - A possible indicator of BRCA founder mutations
Z Einbeigi et al.
ACTA ONCOLOGICA (2002)
Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population
W Hofmann et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Founder mutations in the BRCA1 gene in west Belarusian breast-ovarian cancer families
O Oszurek et al.
CLINICAL GENETICS (2001)
Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)
H Eerola et al.
CANCER CAUSES & CONTROL (2001)
A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer
Z Einbeigi et al.
EUROPEAN JOURNAL OF CANCER (2001)
BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age
JT Bergthorsson et al.
JOURNAL OF MEDICAL GENETICS (2001)
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland
L Sarantaus et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2000)
Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients
K Syrjäkoski et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Founder populations and their uses for breast cancer genetics
SL Neuhausen
BREAST CANCER RESEARCH (2000)
Share Paper
